Heteroaryl imidazolone derivatives as JAK inhibitors

The present invention relates to a compound of formula (I), to the process for preparing such compounds and to their use in the treatment of a pathological condition or disease susceptible to amelioration by sphingosine-1-phosphate receptors (S1P1) agonists.

Saved in:
Bibliographic Details
Main Authors GOMEZ CASTILLO, ELENA, EASTWOOD, PAUL ROBERT, GONZALEZ RODRIGUEZ, JACOB, BACH TANA, JORDI
Format Patent
LanguageChinese
English
Published 16.01.2012
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online AccessGet full text

Cover

More Information
Summary:The present invention relates to a compound of formula (I), to the process for preparing such compounds and to their use in the treatment of a pathological condition or disease susceptible to amelioration by sphingosine-1-phosphate receptors (S1P1) agonists.
Bibliography:Application Number: TW20110120860